Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP526849.RAYoUWg6R0xfvlX4_LeOyL_sXNhORueYrKqkVt5C2iYTE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP526849.RAYoUWg6R0xfvlX4_LeOyL_sXNhORueYrKqkVt5C2iYTE130_assertion type Assertion NP526849.RAYoUWg6R0xfvlX4_LeOyL_sXNhORueYrKqkVt5C2iYTE130_head.
- NP526849.RAYoUWg6R0xfvlX4_LeOyL_sXNhORueYrKqkVt5C2iYTE130_assertion description "[Our data show that Ad-p53 in combination with OBP-301 induces not only oncolytic but also apoptotic cancer cell death and enhances antitumor activity in vitro and in vivo, providing potential merits as a multimodal treatment for human cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526849.RAYoUWg6R0xfvlX4_LeOyL_sXNhORueYrKqkVt5C2iYTE130_provenance.
- NP526849.RAYoUWg6R0xfvlX4_LeOyL_sXNhORueYrKqkVt5C2iYTE130_assertion evidence source_evidence_literature NP526849.RAYoUWg6R0xfvlX4_LeOyL_sXNhORueYrKqkVt5C2iYTE130_provenance.
- NP526849.RAYoUWg6R0xfvlX4_LeOyL_sXNhORueYrKqkVt5C2iYTE130_assertion SIO_000772 20501801 NP526849.RAYoUWg6R0xfvlX4_LeOyL_sXNhORueYrKqkVt5C2iYTE130_provenance.
- NP526849.RAYoUWg6R0xfvlX4_LeOyL_sXNhORueYrKqkVt5C2iYTE130_assertion wasDerivedFrom befree-20150227 NP526849.RAYoUWg6R0xfvlX4_LeOyL_sXNhORueYrKqkVt5C2iYTE130_provenance.
- NP526849.RAYoUWg6R0xfvlX4_LeOyL_sXNhORueYrKqkVt5C2iYTE130_assertion wasGeneratedBy ECO_0000203 NP526849.RAYoUWg6R0xfvlX4_LeOyL_sXNhORueYrKqkVt5C2iYTE130_provenance.